What the study found
Three genome-wide loci were associated with autosomal dominant Alzheimer's disease (ADAD) risk, regardless of which ADAD gene was mutated. The identified loci were CNIH4, CCNG1, and RHOJ.
Why the authors say this matters
The authors conclude that the findings may provide insight into disease biology and highlight the roles of amyloid beta (Aβ), tau, TDP-43, astrocytes, and angiogenesis in Alzheimer's disease. They also state that the study offers insight for family genetic counselling and future clinical trial designs.
What the researchers tested
The researchers conducted a genome-wide association study across three cohorts: the Knight Alzheimer Disease Research Center, the Dominantly Inherited Alzheimer Network observational study, and the Alzheimer's Disease Sequencing Project R4. They analysed whole-genome sequencing data from 101 unrelated, non-Hispanic White symptomatic participants with ADAD mutations and 5050 asymptomatic unrelated controls, with sensitivity analyses that included related participants. They also examined cis-regulatory effects, plasma protein levels, cerebrospinal fluid biomarkers, and neuroimaging data, and assessed associations with age at onset in ADAD and sporadic Alzheimer's disease.
What worked and what didn't
A CNIH4 locus association was driven by a missense variant, Gly54Ser, with a strong association with ADAD risk. The CCNG1 risk allele was associated with higher Alzheimer's disease risk and younger age at dementia onset, and it was also associated with higher plasma TDP-43 levels and a larger gap between chronological age and MRI-predicted brain age. The RHOJ risk allele was associated with higher Alzheimer's disease risk, higher CSF total tau and pTau181, and a lower Aβ42/Aβ40 ratio in DIAN participants. The abstract does not report negative findings beyond noting that these associations were evaluated across mutations and cohorts.
What to keep in mind
The main sequencing analysis was limited to symptomatic non-Hispanic White participants with ADAD mutations and asymptomatic unrelated controls. Some follow-up analyses used smaller samples, including 64 DIAN participants for cerebrospinal fluid and neuroimaging measures. Limitations are not otherwise described in the available abstract.
Key points
- Three genome-wide loci were associated with ADAD risk: CNIH4, CCNG1, and RHOJ.
- The CNIH4 association was driven by the Gly54Ser missense variant.
- The CCNG1 risk allele was associated with higher risk and earlier dementia onset.
- The RHOJ risk allele was associated with higher CSF tau markers and a lower Aβ42/Aβ40 ratio.
- The authors say the findings may inform disease biology, genetic counselling, and clinical trial design.
Disclosure
- Research title:
- Three genetic loci linked to risk in autosomal dominant Alzheimer’s disease
- Image credit:
- Photo by Markus Winkler on Pexels
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.


